What type of study is this?

This is a Systematic Review study.

What question did this study set out to answer?

This review aims to summarize innovative therapeutic approaches for chronic primary pain and evaluate recent clinical trials.

View Full Paper

Ask AI

Bookmark

Authors

Systematic review highlights novel therapeutic targets in chronic primary pain, suggesting new drug development may improve outcomes.

This review aims to summarize innovative therapeutic approaches for chronic primary pain and evaluate recent clinical trials.
Conducted a systematic review of Phases 1–3 clinical trials from January 2014 to July 2024.
Reviewed trials focusing on drug development and repurposing for chronic primary pain conditions.
Analyzed data from clinicaltrials.gov, clinicaltrialsregister.eu, and PubMed.
Identified the lack of breakthroughs in pharmacotherapy for chronic primary pain conditions.
Highlighted the significance of novel therapeutic targets like cannabinoid and neuroinflammatory pathways.
Observed a focus on repurposing existing drugs such as antidepressants and antiepileptics.

Tékus et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark